A modified Drug Attitude Inventory used in long-term patients in sheltered housing.
Stjernswärd, Sigrid LU
; Persson, Karin
LU
; Nielsen, René
; Tuninger, Eva
LU
and Levander, Sten
LU
(2013)
In European Neuropsychopharmacology
23(10).
p.1296-1299
- Abstract
- The self-report Drug Attitude Inventory (DAI), in 30- and 10-item versions, provides unique information of clinical relevance for monitoring treatment adherence among people diagnosed with schizophrenia. The primary purpose of this paper was to evaluate the 10-item version among patients living in sheltered housing. Data were collected among 68 persons living in sheltered housing, most of them (82%) diagnosed with schizophrenia, 6% with non-organic psychoses, and 12% with other diagnoses. The dichotomic response format of the original DAI-10 was replaced by a 4-point Likert scale, in order to improve the resolution of the scale. Over 90% of the participants produced meaningful scores. A factor analysis suggested a 2-factor orthogonal... (More)
- The self-report Drug Attitude Inventory (DAI), in 30- and 10-item versions, provides unique information of clinical relevance for monitoring treatment adherence among people diagnosed with schizophrenia. The primary purpose of this paper was to evaluate the 10-item version among patients living in sheltered housing. Data were collected among 68 persons living in sheltered housing, most of them (82%) diagnosed with schizophrenia, 6% with non-organic psychoses, and 12% with other diagnoses. The dichotomic response format of the original DAI-10 was replaced by a 4-point Likert scale, in order to improve the resolution of the scale. Over 90% of the participants produced meaningful scores. A factor analysis suggested a 2-factor orthogonal structure: one highly homogenous factor (5 items) reflected wanted effects of the drug and displayed a bimodal distribution; one factor (3 items) reflected side effects. One item concerned the perceived control over one's drug treatment, which is a key clinical issue. One item was conceptually ambiguous and displayed no correlations with the other items. On the basis of the results we suggest cut-off scores which indicate the need for three kinds of adherence-improving interventions. Summing up, by dropping one item and using a Likert scale response format, the resulting instrument, DAI-9, appears to be an easy-to-use self-report instrument for monitoring drug attitudes and to identify needs for treatment adherence interventions among seriously ill patients. (Less)
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/3346907
- author
- Stjernswärd, Sigrid
LU
; Persson, Karin
LU
; Nielsen, René
; Tuninger, Eva
LU
and Levander, Sten
LU
- organization
- publishing date
- 2013
- type
- Contribution to journal
- publication status
- published
- subject
- in
- European Neuropsychopharmacology
- volume
- 23
- issue
- 10
- pages
- 1296 - 1299
- publisher
- Elsevier
- external identifiers
-
- wos:000325833500016
- pmid:23265955
- scopus:84884290346
- pmid:23265955
- ISSN
- 1873-7862
- DOI
- 10.1016/j.euroneuro.2012.11.011
- language
- English
- LU publication?
- yes
- additional info
- The information about affiliations in this record was updated in December 2015. The record was previously connected to the following departments: Psychiatry (Lund) (013303000), Division of Nursing (Closed 2012) (013065000), Faculty of Medicine (000022000), Longitudinal Studies in Clinical Psychiatry (013243120)
- id
- bbd8e072-cc69-4434-b159-a04753f3779a (old id 3346907)
- alternative location
- http://www.ncbi.nlm.nih.gov/pubmed/23265955?dopt=Abstract
- date added to LUP
- 2016-04-01 10:08:48
- date last changed
- 2022-03-19 17:45:14
@article{bbd8e072-cc69-4434-b159-a04753f3779a,
abstract = {{The self-report Drug Attitude Inventory (DAI), in 30- and 10-item versions, provides unique information of clinical relevance for monitoring treatment adherence among people diagnosed with schizophrenia. The primary purpose of this paper was to evaluate the 10-item version among patients living in sheltered housing. Data were collected among 68 persons living in sheltered housing, most of them (82%) diagnosed with schizophrenia, 6% with non-organic psychoses, and 12% with other diagnoses. The dichotomic response format of the original DAI-10 was replaced by a 4-point Likert scale, in order to improve the resolution of the scale. Over 90% of the participants produced meaningful scores. A factor analysis suggested a 2-factor orthogonal structure: one highly homogenous factor (5 items) reflected wanted effects of the drug and displayed a bimodal distribution; one factor (3 items) reflected side effects. One item concerned the perceived control over one's drug treatment, which is a key clinical issue. One item was conceptually ambiguous and displayed no correlations with the other items. On the basis of the results we suggest cut-off scores which indicate the need for three kinds of adherence-improving interventions. Summing up, by dropping one item and using a Likert scale response format, the resulting instrument, DAI-9, appears to be an easy-to-use self-report instrument for monitoring drug attitudes and to identify needs for treatment adherence interventions among seriously ill patients.}},
author = {{Stjernswärd, Sigrid and Persson, Karin and Nielsen, René and Tuninger, Eva and Levander, Sten}},
issn = {{1873-7862}},
language = {{eng}},
number = {{10}},
pages = {{1296--1299}},
publisher = {{Elsevier}},
series = {{European Neuropsychopharmacology}},
title = {{A modified Drug Attitude Inventory used in long-term patients in sheltered housing.}},
url = {{https://lup.lub.lu.se/search/files/1602938/3460878.pdf}},
doi = {{10.1016/j.euroneuro.2012.11.011}},
volume = {{23}},
year = {{2013}},
}